Sleep-focused neurotech firm Dreem raises $35M from Johnson&Johnson Innovation and Bpifrance

___ Dreem Announces $35 Mil­lion Financ­ing from lead investors John­son & John­son Inno­va­tion and Bpifrance (press release): “Dreem, a neu­rotech­nol­o­gy com­pa­ny, today announced the clos­ing of a new round of fund­ing, rais­ing $35 mil­lion USD to rapid­ly accel­er­ate prod­uct devel­op­ment, invest in strate­gic research and devel­op­ment, and advance the future of sleep tech­nol­o­gy. Last year,…

Read More